(Total Views: 387)
Posted On: 04/26/2019 1:42:02 PM
Post# of 72446
The Brilacidin-OM clinical trial will be, as clinical trials go, inexpensive.
The Bril-ABSSSI clinical trial was estimated to cost about 30 million because of the very long time it would take to recruit clinical trial participants in a very large number of sites, the high costs of IV administration in a hospital, and the difficulty of assessing what would be a "success" in a population with severe infections that could takes months to resolve.
As a contrast, Bril-OM will be cheap to administer (powdered-form sachets, mixed and used by the patient) and results will be available quite quickly -- a matter of a couple months at the most to see if OM develops and if so, how severe it is.
Estimates of 50-100 million for a clinical trial of any of IPIX's drugs are completely out of the ballpark. No evidence of those kinds of costs.
The Bril-ABSSSI clinical trial was estimated to cost about 30 million because of the very long time it would take to recruit clinical trial participants in a very large number of sites, the high costs of IV administration in a hospital, and the difficulty of assessing what would be a "success" in a population with severe infections that could takes months to resolve.
As a contrast, Bril-OM will be cheap to administer (powdered-form sachets, mixed and used by the patient) and results will be available quite quickly -- a matter of a couple months at the most to see if OM develops and if so, how severe it is.
Estimates of 50-100 million for a clinical trial of any of IPIX's drugs are completely out of the ballpark. No evidence of those kinds of costs.
(1)
(0)
